Origin Agritech Announces Receipt of Nasdaq Notice Regarding Minimum Bid Price Requirement
Shares continue trading, but failure to cure the deficiency or qualify for more time could lead to a delisting determination.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Origin Agritech (NASDAQ: SEED) received a Nasdaq minimum bid price deficiency notice on October 27, 2026, after its shares fell below listing requirements. The closing bid price had been below $1.00 for 30 consecutive business days. The notice has no immediate effect on listing, and shares continue trading on The Nasdaq Capital Market.
The company has until April 26, 2027 to regain compliance by maintaining a closing bid price of at least $1.00 for at least 10 consecutive business days; Nasdaq may require a longer period. A further 180-calendar-day compliance period is conditional on meeting other listing standards and providing written notice of an intention to cure the deficiency. Origin intends to consider available options, including a reverse stock split if necessary.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate pointNasdaq granted 180 calendar days, until April 26, 2027, to regain bid price compliance.
Negative
- Moderate pointClosing bid price below $1.00 for 30 consecutive business days triggered a Nasdaq listing deficiency.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Delisting determination may follow if Origin cannot qualify for more time or Nasdaq sees no ability to cure.
- Minor point. Forward-looking: it has not happened yet and may not happen.Additional 180-calendar-day period requires other listing standards and written intention to cure, including a reverse split if necessary.
Key Figures
- Minimum bid-price threshold
- $1.00 per share
- The company's closing bid price was below this continued-listing requirement
- Time below threshold
- 30 consecutive business days
- Period cited in Nasdaq's deficiency notice
- Initial compliance period
- 180 calendar days, through April 26, 2027
- Period to regain compliance
- Required bid-price duration
- At least 10 consecutive business days
- Closing bid price must be at least $1.00 per share
- Possible additional compliance period
- 180 calendar days
- May be available if the company does not regain compliance by April 26, 2027 and meets other criteria
- Possible extended bid-price test
- Generally no more than 20 consecutive business days
- Nasdaq may require a longer period above the minimum bid price
Key Terms
reverse stock split financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
BEIJING, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Origin Agritech Limited (NASDAQ: SEED) ("Origin" or the "Company"), a leading Chinese agricultural technology company, today announced that on October 27, 2026, it received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") stating that, for the last 30 consecutive business days, the closing bid price of the Company’s ordinary shares had been below the minimum
The Notice has no immediate effect on the listing of the Company’s ordinary shares, which will continue to trade on The Nasdaq Capital Market under the symbol "SEED."
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a compliance period of 180 calendar days, or until April 26, 2027, to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the closing bid price of the Company’s ordinary shares must be at least
If the Company does not regain compliance by April 26, 2027, the Company may be eligible for an additional 180-calendar-day compliance period. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written Notice to Nasdaq of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company does not qualify for the second compliance period, or if it appears to Nasdaq that the Company will not be able to cure the deficiency, Nasdaq will provide written Notice that the Company’s ordinary shares are subject to delisting. At that time, the Company will be entitled to appeal the delisting determination to a Nasdaq Hearings Panel.
The Company intends to actively monitor the closing bid price of its ordinary shares and will consider available options to regain compliance with the Minimum Bid Price Requirement within the compliance period, which may include, if necessary, effecting a reverse stock split. There can be no assurance, however, that the Company will be able to regain compliance with the Minimum Bid Price Requirement or maintain compliance with Nasdaq’s other continued listing requirements.
This press release is being issued in accordance with Nasdaq Listing Rule 5810(b), which requires the Company to publicly disclose its receipt of the Notice. The Company will also furnish a copy of this press release to the U.S. Securities and Exchange Commission on Form 6-K.
About Origin Agritech Limited
Origin Agritech Limited, founded in 1997 and headquartered at the Origin R&D Center in Songzhuang, Tongzhou, Beijing, is a leading Chinese agricultural technology company. In crop seed biotechnology, Origin Agritech’s phytase corn was the first transgenic corn to receive a Biosafety Certificate from China’s Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed pipeline, including products with glyphosate tolerance and Bt (pest resistance) traits. For further information, please visit the Company’s website at https://originagritech.com. The Company also maintains an X account to update investors on Company and industry developments, available at https://x.com/origin_agritech.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s intention to monitor the bid price of its ordinary shares, its plans to regain compliance with the Minimum Bid Price Requirement, the potential for a reverse stock split, the Company’s eligibility for an additional compliance period, and the continued listing of the Company’s ordinary shares on The Nasdaq Capital Market.
Words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "will," "would," "may," "target," and similar expressions identify forward-looking statements. These statements involve known and unknown risks and uncertainties, including the market price and trading volume of the Company’s ordinary shares, the Company’s ability to regain and maintain compliance with Nasdaq’s continued listing requirements, the outcome of any action the Company may take to regain compliance, Nasdaq’s discretion in applying its listing rules, regulatory and agricultural policy developments in China, and the Company’s ability to fund and execute its plans. These and other factors may cause actual results to differ materially from those expressed or implied by the forward-looking statements.
There can be no assurance that the Company will regain compliance with the Minimum Bid Price Requirement within the compliance period, that the Company will qualify for any additional compliance period, or that the Company’s ordinary shares will remain listed on The Nasdaq Capital Market.
Forward-looking statements are not guarantees of future performance. Origin Agritech undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by securities and other applicable laws.
For more information, please contact:
Origin Agritech Limited Contact:
Kate Lang (Mandarin/English)
Director of Investor Relations
Phone: +86 186-1839-3368
Email: bing.lang@originseed.com.cn
Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What must Origin Agritech do to regain Nasdaq bid price compliance?
Origin must maintain a closing bid price of at least $1.00 per share for at least 10 consecutive business days during the compliance period ending April 26, 2027. Nasdaq may require more than ten consecutive business days, but generally no more than 20, before confirming compliance in writing.
What listing standards must Origin Agritech meet for an additional Nasdaq compliance period?
Origin must meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market except the bid price requirement. It must also notify Nasdaq in writing of its intention to cure the deficiency during the second compliance period, through a reverse stock split if necessary.
Can Origin Agritech appeal a Nasdaq delisting determination?
Origin would be entitled to appeal to a Nasdaq Hearings Panel if Nasdaq issues a delisting determination. Such a determination could follow if the company does not qualify for a second compliance period or Nasdaq concludes that it will not be able to cure the deficiency.